10-KThe Record
TELA Bio, Inc. files 10-K
Filed Mar 25, 2026 · 3mo ago · Accession 0001104659-26-034507
Plain English
TELA Bio, Inc. reported an increase in revenue for the year ended December 31, 2025, driven by higher unit sales of its OviTex and OviTex PRS products. However, the company also experienced an increase in its net loss compared to the prior year, primarily due to increased operating expenses.
Filing details
- Company
- TELA Bio, Inc.
- Ticker
- TELA
- CIK
- 1561921
- Form type
- 10-K
- Filing date
- Mar 25, 2026
- Report date
- Dec 31, 2025
- Document
- tela-20251231x10k.htm
- Size
- 11.5 MB